Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2014

01-10-2014 | Research Article

Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals

Authors: Isabel Brazinha, Fernando Fernandez-Llimos

Published in: International Journal of Clinical Pharmacy | Issue 5/2014

Login to get access

Abstract

Background In some countries, such as Portugal, clinical pharmacy services in the hospital setting may be implemented to a lower extent than desirable. Several studies have analysed the perceived barriers to pharmacy service implementation in community pharmacy. Objective To identify the barriers towards the implementation of advanced clinical pharmacy services at a hospital level in Portugal, using medication follow-up as an example. Setting Hospital pharmacies in Portugal. Methods A qualitative study based on 20 face-to-face semi-structured interviews of strategists and hospital pharmacists. The interview guide was based on two theoretical frameworks, the Borum’s theory of organisational change and the Social Network Theory, and then adapted for the Portuguese reality and hospital environments. A constant comparison process with previously analysed interviews, using an inductive approach, was carried out to allow themes to emerge. Themes were organised following the Leavitt’s Organizational Model: functions and objectives; hospital pharmacist; structure of pharmacy services; environment; technology; and medication follow-up based on the study topic. Main outcome measure Barriers towards practice change. Results Medication follow-up appeared not to be a well-known service in Portuguese hospital pharmacies. The major barriers at the pharmacist level were their mind-set, resistance to change, and lack of readiness. Lack of time, excessive bureaucratic and administrative workload, reduced workforce, and lack of support from the head of the service and other colleagues were identified as structural barriers. Lack of access to patients’ clinical records and cumbersome procedures to implement medication follow-up were recognised as technological barriers. Poor communication with other healthcare professionals, and lack of support from professional associations were the major environmental barriers. Conclusion Few of the barriers identified by Portuguese hospital pharmacists were consistent with previous reports from community pharmacy. The mind-set of pharmacists and predetermined attitudes are recognised as barriers that can give rise to new perceived barriers.
Literature
3.
go back to reference Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.PubMedCrossRef Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.PubMedCrossRef
4.
go back to reference Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27(4):481–93.PubMedCrossRef Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27(4):481–93.PubMedCrossRef
5.
go back to reference American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy. 2008;28(6):816–7.CrossRef American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy. 2008;28(6):816–7.CrossRef
6.
go back to reference Moullin JC, Sabater-Hernandez D, Fernandez-Llimos F, Benrimoj SI. Defining professional pharmacy services in community pharmacy. Res Social Adm Pharm. 2013;9(6):989–95.PubMedCrossRef Moullin JC, Sabater-Hernandez D, Fernandez-Llimos F, Benrimoj SI. Defining professional pharmacy services in community pharmacy. Res Social Adm Pharm. 2013;9(6):989–95.PubMedCrossRef
7.
go back to reference van Mil JW, Fernandez-Llimos F. What is ‘pharmaceutical care’ in 2013? Int J Clin Pharm. 2013;35(1):1–2.PubMedCrossRef van Mil JW, Fernandez-Llimos F. What is ‘pharmaceutical care’ in 2013? Int J Clin Pharm. 2013;35(1):1–2.PubMedCrossRef
8.
go back to reference American Pharmacists Association, National Association of Chain Drug Stores Foundation (2008) Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc 48(3):341–353. American Pharmacists Association, National Association of Chain Drug Stores Foundation (2008) Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc 48(3):341–353.
9.
go back to reference Benrimoj SI, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Faus MJ. A holistic and integrated approach to implementing cognitive pharmaceutical services. Ars Pharm. 2010;51(2):69–87. Benrimoj SI, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Faus MJ. A holistic and integrated approach to implementing cognitive pharmaceutical services. Ars Pharm. 2010;51(2):69–87.
10.
go back to reference Sabater-Hernandez D, Faus MJ, Fikri-Benbrahim N, Garcia-Cardenas V. Overall results of the Dader Pharmacotherapeutic Follow-Up Program data base: 2008. Aten Primaria. 2010;42(5):297–8.PubMedCrossRef Sabater-Hernandez D, Faus MJ, Fikri-Benbrahim N, Garcia-Cardenas V. Overall results of the Dader Pharmacotherapeutic Follow-Up Program data base: 2008. Aten Primaria. 2010;42(5):297–8.PubMedCrossRef
11.
go back to reference Correr CJ, Melchiors AC, Fernandez-Llimos F, Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm. 2011;33(2):273–80.PubMedCrossRef Correr CJ, Melchiors AC, Fernandez-Llimos F, Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm. 2011;33(2):273–80.PubMedCrossRef
12.
go back to reference Armando P, Semeria N, Tenllado M, Sola N. Pharmacotherapeutic follow-up of patients in community pharmacies. Aten Primaria. 2005;36(3):129–34.PubMedCrossRef Armando P, Semeria N, Tenllado M, Sola N. Pharmacotherapeutic follow-up of patients in community pharmacies. Aten Primaria. 2005;36(3):129–34.PubMedCrossRef
13.
go back to reference Chemello C, Aguilera M, Calleja-Hernandez MA, Faus MJ. Effect of pharmaceutical follow-up in patients with secondary hyperparathyroidism treated with cinacalcet. Farm Hosp. 2012;36(5):321–7.PubMedCrossRef Chemello C, Aguilera M, Calleja-Hernandez MA, Faus MJ. Effect of pharmaceutical follow-up in patients with secondary hyperparathyroidism treated with cinacalcet. Farm Hosp. 2012;36(5):321–7.PubMedCrossRef
14.
go back to reference Figueiredo IV, Moteiro C, Castel-Branco MM, Caramona MM, Fernandez-Llimos F. Medication follow-up in type 2 diabetes patients at a primary health care center. Pharm Care Esp. 2014;17(2):39–48. Figueiredo IV, Moteiro C, Castel-Branco MM, Caramona MM, Fernandez-Llimos F. Medication follow-up in type 2 diabetes patients at a primary health care center. Pharm Care Esp. 2014;17(2):39–48.
15.
go back to reference LeBlanc JM, Seoane-Vazquez E, Dasta JF. Survey of hospital pharmacist activities outside of the United States. Am J Health Syst Pharm. 2007;64(16):1748–55.PubMedCrossRef LeBlanc JM, Seoane-Vazquez E, Dasta JF. Survey of hospital pharmacist activities outside of the United States. Am J Health Syst Pharm. 2007;64(16):1748–55.PubMedCrossRef
17.
go back to reference Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education–2012. Am J Health Syst Pharm. 2013;70(9):787–803.PubMedCrossRef Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education–2012. Am J Health Syst Pharm. 2013;70(9):787–803.PubMedCrossRef
18.
go back to reference Stuchbery P, Kong DCM, DeSantis GN, Lo SK. Identification by observation of clinical pharmacists’ activities in a hospital inpatient setting. Pharm Pract. 2007;5(1):10–6. Stuchbery P, Kong DCM, DeSantis GN, Lo SK. Identification by observation of clinical pharmacists’ activities in a hospital inpatient setting. Pharm Pract. 2007;5(1):10–6.
19.
go back to reference Child D, Cantrill J, Cooke J. The effectiveness of hospital pharmacy in the UK: methodology for finding the evidence. Pharm World Sci. 2004;26(1):44–51.PubMedCrossRef Child D, Cantrill J, Cooke J. The effectiveness of hospital pharmacy in the UK: methodology for finding the evidence. Pharm World Sci. 2004;26(1):44–51.PubMedCrossRef
20.
go back to reference Campbell G, Auyeung V, McRobbie D. Clinical pharmacy services in a London hospital, have they changed? Int J Clin Pharm. 2013;35(5):688–91.PubMedCrossRef Campbell G, Auyeung V, McRobbie D. Clinical pharmacy services in a London hospital, have they changed? Int J Clin Pharm. 2013;35(5):688–91.PubMedCrossRef
21.
go back to reference Silva CMM, Calleja HMA, Tuneu i Valls L, Fuentes CB, Gutierrez SJ, Faus DMJ. Drug therapy follow-up in patients admitted to a surgery department. Farm Hosp. 2004;28(3):154–69. Silva CMM, Calleja HMA, Tuneu i Valls L, Fuentes CB, Gutierrez SJ, Faus DMJ. Drug therapy follow-up in patients admitted to a surgery department. Farm Hosp. 2004;28(3):154–69.
22.
go back to reference Prot-Labarthe S, Lavoie A, Bourdon O, Lebel D, Bussieres JF, Faye A, Brion F. Pilot study about pharmaceutical care implantation in a general paediatric unit in a French hospital. France-Quebec collaboration and comparison. Arch Pediatr. 2007;14(4):345–53.PubMedCrossRef Prot-Labarthe S, Lavoie A, Bourdon O, Lebel D, Bussieres JF, Faye A, Brion F. Pilot study about pharmaceutical care implantation in a general paediatric unit in a French hospital. France-Quebec collaboration and comparison. Arch Pediatr. 2007;14(4):345–53.PubMedCrossRef
23.
go back to reference Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L, Tulkens PM. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55(5):658–65.PubMedCrossRef Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L, Tulkens PM. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55(5):658–65.PubMedCrossRef
24.
go back to reference Bosma L, Jansman FG, Franken AM, Harting JW, Van den Bemt PM. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci. 2008;30(1):31–8.PubMedCrossRef Bosma L, Jansman FG, Franken AM, Harting JW, Van den Bemt PM. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci. 2008;30(1):31–8.PubMedCrossRef
25.
go back to reference Veggeland T, Dyb S. The contribution of a clinical pharmacist to the improvement of medication at a geriatric hospital unit in Norway. Pharm Pract. 2008;6(1):20–4. Veggeland T, Dyb S. The contribution of a clinical pharmacist to the improvement of medication at a geriatric hospital unit in Norway. Pharm Pract. 2008;6(1):20–4.
26.
go back to reference Bergkvist Christensen A, Holmbjer L, Midlov P, Hoglund P, Larsson L, Bondesson A, Eriksson T. The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm. 2011;33(6):1010–8.PubMedCrossRef Bergkvist Christensen A, Holmbjer L, Midlov P, Hoglund P, Larsson L, Bondesson A, Eriksson T. The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm. 2011;33(6):1010–8.PubMedCrossRef
27.
go back to reference Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm. 2012;34(6):828–31.PubMedCrossRef Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm. 2012;34(6):828–31.PubMedCrossRef
28.
go back to reference Ribeiro N, Cavaco P, Falcao F, editors (2008) Implementation of Dader methodology for pharmacotherapy follow-up in hospitalized geriatric patients. ESCP 36th European Symposium on Clinical Pharmacy‘Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience; 2007; Istanbul, Turkey: Pharm World Sci 30: 649–740. Ribeiro N, Cavaco P, Falcao F, editors (2008) Implementation of Dader methodology for pharmacotherapy follow-up in hospitalized geriatric patients. ESCP 36th European Symposium on Clinical Pharmacy‘Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience; 2007; Istanbul, Turkey: Pharm World Sci 30: 649–740.
29.
go back to reference Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.PubMedPubMedCentralCrossRef Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.PubMedPubMedCentralCrossRef
30.
go back to reference Fernandez-Llimos F, Silva TA. Implementation of the protocol on pharmaceutical care in diabetes in Portugal. Pharm World Sci. 2009;31(4):495. Fernandez-Llimos F, Silva TA. Implementation of the protocol on pharmaceutical care in diabetes in Portugal. Pharm World Sci. 2009;31(4):495.
31.
go back to reference Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–65.PubMedCrossRef Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–65.PubMedCrossRef
32.
go back to reference Cochrane LJ, Olson CA, Murray S, Dupuis M, Tooman T, Hayes S. Gaps between knowing and doing: understanding and assessing the barriers to optimal health care. J Contin Educ Health Prof. 2007;27(2):94–102.PubMedCrossRef Cochrane LJ, Olson CA, Murray S, Dupuis M, Tooman T, Hayes S. Gaps between knowing and doing: understanding and assessing the barriers to optimal health care. J Contin Educ Health Prof. 2007;27(2):94–102.PubMedCrossRef
33.
go back to reference Odedina FT, Segal R, Hepler CD, Lipowski E, Kimberlin C. Changing pharmacists’ practice pattern: pharmacists’ implementation of pharmaceutical care factors. J Soc Adm Pharm. 1996;13:74–88. Odedina FT, Segal R, Hepler CD, Lipowski E, Kimberlin C. Changing pharmacists’ practice pattern: pharmacists’ implementation of pharmaceutical care factors. J Soc Adm Pharm. 1996;13:74–88.
34.
go back to reference van Mil JWF, De Boer WO, Tromp TFJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract. 2001;9(3):163–8.CrossRef van Mil JWF, De Boer WO, Tromp TFJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract. 2001;9(3):163–8.CrossRef
35.
go back to reference Rossing C, Hansen EH, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacies. J Soc Adm Pharm. 2001;19:55–64. Rossing C, Hansen EH, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacies. J Soc Adm Pharm. 2001;19:55–64.
36.
go back to reference Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–30.PubMedCrossRef Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–30.PubMedCrossRef
37.
go back to reference Hidalgo J, Cámara D, Baena MI, Fajardo PC, Martínez-Martínez F. Barriers for implementing pharmacotherapy follow-up in community pharmacies from Granada (Spain). Seguim Farmacoter. 2005;3(3):144–9. Hidalgo J, Cámara D, Baena MI, Fajardo PC, Martínez-Martínez F. Barriers for implementing pharmacotherapy follow-up in community pharmacies from Granada (Spain). Seguim Farmacoter. 2005;3(3):144–9.
38.
go back to reference Gastelurrutia MA, Fernandez-Llimos F, García-Delgado P, Gastelurrutia P, Faus MJ, Benrimoj SI. Barriers and facilitators to the dissemination and implementation of cognitive services in Spanish community pharmacies. Seguim Farmacoter. 2005;3(2):65–77. Gastelurrutia MA, Fernandez-Llimos F, García-Delgado P, Gastelurrutia P, Faus MJ, Benrimoj SI. Barriers and facilitators to the dissemination and implementation of cognitive services in Spanish community pharmacies. Seguim Farmacoter. 2005;3(2):65–77.
39.
go back to reference Lounsbery JL, Green CG, Bennett MS, Pedersen CA. Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. J Am Pharm Assoc. 2009;49(1):51–8.CrossRef Lounsbery JL, Green CG, Bennett MS, Pedersen CA. Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. J Am Pharm Assoc. 2009;49(1):51–8.CrossRef
40.
go back to reference MacIntosh C, Weiser C, Wassimi A, Reddick J, Scovis N, Guy M, Boesen K. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists. J Am Pharm Assoc. 2009;49(1):26–30.CrossRef MacIntosh C, Weiser C, Wassimi A, Reddick J, Scovis N, Guy M, Boesen K. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists. J Am Pharm Assoc. 2009;49(1):26–30.CrossRef
41.
go back to reference Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–31.PubMedCrossRef Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–31.PubMedCrossRef
42.
go back to reference Fang Y, Yang S, Feng B, Ni Y, Zhang K. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health Soc Care Community. 2011;19(2):189–97.PubMed Fang Y, Yang S, Feng B, Ni Y, Zhang K. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health Soc Care Community. 2011;19(2):189–97.PubMed
43.
go back to reference Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.PubMedCrossRef Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.PubMedCrossRef
44.
go back to reference Liekens S, Smits T, Laekeman G, Foulon V. Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. Int J Clin Pharm. 2012;34(3):452–9.PubMedCrossRef Liekens S, Smits T, Laekeman G, Foulon V. Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. Int J Clin Pharm. 2012;34(3):452–9.PubMedCrossRef
45.
go back to reference Cotter SM, Barber ND, McKee M, Chalmers CP. Factors influencing the provision of clinical pharmacy services in United Kingdom National Health Service hospitals. Int J Technol Assess Health Care. 1996;12(3):475–86.PubMed Cotter SM, Barber ND, McKee M, Chalmers CP. Factors influencing the provision of clinical pharmacy services in United Kingdom National Health Service hospitals. Int J Technol Assess Health Care. 1996;12(3):475–86.PubMed
46.
go back to reference Awad A, Al-Ebrahim S, Abahussain E. Pharmaceutical care services in hospitals of Kuwait. J Pharm Pharm Sci. 2006;9(2):149–57.PubMed Awad A, Al-Ebrahim S, Abahussain E. Pharmaceutical care services in hospitals of Kuwait. J Pharm Pharm Sci. 2006;9(2):149–57.PubMed
47.
go back to reference Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30(3):211–5.PubMedCrossRef Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30(3):211–5.PubMedCrossRef
48.
go back to reference Roberts AS, Hopp T, Sorensen EW, Benrimoj SI, Chen TF, Herborg H, Williams K, Aslani P. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci. 2003;25(5):227–34.PubMedCrossRef Roberts AS, Hopp T, Sorensen EW, Benrimoj SI, Chen TF, Herborg H, Williams K, Aslani P. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci. 2003;25(5):227–34.PubMedCrossRef
49.
go back to reference Gastelurrutia MA, Fernandez-Llimos F, Benrimoj SI, Castrillon CC, Faus MJ. Barriers for the implementation of cognitive services in Spanish community pharmacies. Aten Primaria. 2007;39(9):465–70.PubMedCrossRef Gastelurrutia MA, Fernandez-Llimos F, Benrimoj SI, Castrillon CC, Faus MJ. Barriers for the implementation of cognitive services in Spanish community pharmacies. Aten Primaria. 2007;39(9):465–70.PubMedCrossRef
50.
go back to reference Borum F. Organization, power and change. Copenhagen: Handelshøjskolens Forlag; 1995. Borum F. Organization, power and change. Copenhagen: Handelshøjskolens Forlag; 1995.
51.
go back to reference Lundin RA, Soderholm A. A theory of the temporary organization. Scand J Manag. 1995;11(4):437–55.CrossRef Lundin RA, Soderholm A. A theory of the temporary organization. Scand J Manag. 1995;11(4):437–55.CrossRef
52.
go back to reference Charmaz K, Bryant A. Grounded theory. In: Given LM, editor. In: the Sage Encyclopedia of qualitative research methods. Thousand Oaks, CA: Sage; 2008. Charmaz K, Bryant A. Grounded theory. In: Given LM, editor. In: the Sage Encyclopedia of qualitative research methods. Thousand Oaks, CA: Sage; 2008.
53.
go back to reference Lioness A. Thematic coding and analysis. In: Given LM, editor. The Sage Encyclopedia of qualitative research methods. Thousand Oaks: Sage; 2008. Lioness A. Thematic coding and analysis. In: Given LM, editor. The Sage Encyclopedia of qualitative research methods. Thousand Oaks: Sage; 2008.
54.
go back to reference Leavitt HJ. Applied organizational change in industry. In: March JG, editor. Handbook of organizations. New York: Rand McNally; 1965. Leavitt HJ. Applied organizational change in industry. In: March JG, editor. Handbook of organizations. New York: Rand McNally; 1965.
55.
go back to reference Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study. Int J Clin Pharm. 2012;34(4):569–78.PubMedCrossRef Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study. Int J Clin Pharm. 2012;34(4):569–78.PubMedCrossRef
56.
go back to reference Zardain E, del Valle MO, Loza MI, Garcia E, Lana A, Markham WA, Lopez ML. Psychosocial and behavioural determinants of the implementation of Pharmaceutical Care in Spain. Pharm World Sci. 2009;31(2):174–82.PubMedCrossRef Zardain E, del Valle MO, Loza MI, Garcia E, Lana A, Markham WA, Lopez ML. Psychosocial and behavioural determinants of the implementation of Pharmaceutical Care in Spain. Pharm World Sci. 2009;31(2):174–82.PubMedCrossRef
57.
go back to reference Gouveia WA. Transition to managed care, part 2. Am J Health Syst Pharm. 1998;55(4):347.PubMed Gouveia WA. Transition to managed care, part 2. Am J Health Syst Pharm. 1998;55(4):347.PubMed
58.
go back to reference Cousins D. Current status of the monitoring of medication practice. Am J Health Syst Pharm. 2009;66(5 Suppl 3):S49–56.PubMedCrossRef Cousins D. Current status of the monitoring of medication practice. Am J Health Syst Pharm. 2009;66(5 Suppl 3):S49–56.PubMedCrossRef
59.
go back to reference Fernandez-Llimos F, Faus MJ. From “drug-related problems” to “negative clinical outcomes”. Am J Health Syst Pharm. 2005;62(22):2348–50.PubMedCrossRef Fernandez-Llimos F, Faus MJ. From “drug-related problems” to “negative clinical outcomes”. Am J Health Syst Pharm. 2005;62(22):2348–50.PubMedCrossRef
60.
go back to reference Ambrose PJ, Saya FG, Lovett LT, Tan S, Adams DW, Shane R. Evaluating the accuracy of technicians and pharmacists in checking unit dose medication cassettes. Am J Health Syst Pharm. 2002;59(12):1183–8.PubMed Ambrose PJ, Saya FG, Lovett LT, Tan S, Adams DW, Shane R. Evaluating the accuracy of technicians and pharmacists in checking unit dose medication cassettes. Am J Health Syst Pharm. 2002;59(12):1183–8.PubMed
61.
go back to reference van den Bemt PM, van den Broek S, van Nunen AK, Harbers JB, Lenderink AW. Medication reconciliation performed by pharmacy technicians at the time of preoperative screening. Ann Pharmacother. 2009;43(5):868–74.PubMedCrossRef van den Bemt PM, van den Broek S, van Nunen AK, Harbers JB, Lenderink AW. Medication reconciliation performed by pharmacy technicians at the time of preoperative screening. Ann Pharmacother. 2009;43(5):868–74.PubMedCrossRef
62.
go back to reference Dualde E, Faus MJ, Santonja FJ, Fernandez-Llimos F. Effectiveness of a videoconference training course on implementing pharmacy services. Pharm World Sci. 2009;31(6):638–42.PubMedCrossRef Dualde E, Faus MJ, Santonja FJ, Fernandez-Llimos F. Effectiveness of a videoconference training course on implementing pharmacy services. Pharm World Sci. 2009;31(6):638–42.PubMedCrossRef
63.
go back to reference Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Exploring the role of pharmacists in outpatient dialysis centers: a qualitative study of nephrologist views. Nephrol Dial Transplant. 2013;28(2):397–404.PubMedCrossRef Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Exploring the role of pharmacists in outpatient dialysis centers: a qualitative study of nephrologist views. Nephrol Dial Transplant. 2013;28(2):397–404.PubMedCrossRef
Metadata
Title
Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals
Authors
Isabel Brazinha
Fernando Fernandez-Llimos
Publication date
01-10-2014
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2014
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-9991-0

Other articles of this Issue 5/2014

International Journal of Clinical Pharmacy 5/2014 Go to the issue